U.S. Capital Markets Stock News

Fluence Energy (FLNC) moved back into focus after Jefferies upgraded the stock, pointing to robust U.S. market conditions, a record project backlog, and reaffirmed revenue targets supported by substantial new orders. See our latest analysis for Fluence Energy. Jefferies’ upgrade lands after a sharp reset in sentiment, with a 51.10% 30 day share price return decline and a 31.51% year to date share price return decline. At the same time, the 1 year total shareholder return is 198.48% and the 3...

Recent Share Performance and Business Snapshot Full Truck Alliance (YMM) has drawn fresh attention after a period of weaker share performance, with the stock showing negative returns over the past week, month and past 3 months. At a last close of US$8.94, the company sits against a backdrop of reported revenue of CN¥12,471.511 and net income of CN¥3,978.797, alongside annual revenue and net income growth figures. See our latest analysis for Full Truck Alliance. The recent 1 day share price...

Zai Lab Limited recently reported past fourth-quarter 2025 results, with revenue rising to US$127.6 million from US$109.07 million and net loss narrowing to US$50.41 million from US$81.68 million a year earlier. The reduced basic loss per share from continuing operations, improving to US$0.50 from US$0.80, highlights meaningful progress in containing costs alongside revenue growth. Next, we will examine how Zai Lab’s improved revenue and narrower loss shape the existing investment narrative...

In late February 2026, IBM announced a collaboration to embed Deepgram’s voice AI into watsonx Orchestrate and secured a US$112.00 million, up-to-five-year Defense Commissary Agency contract to upgrade and maintain electronic shelf labels across 235 commissaries worldwide. Taken together with the recent expansion of IBM’s board to fourteen directors, these moves highlight how the company is deepening its focus on enterprise-grade AI, automation, and mission-critical government...

Strategic Education (STRA) is back in focus after reporting fourth quarter and full year 2025 results that highlighted higher revenue, stronger margins, and record contributions from several high margin units supported by AI driven cost savings. See our latest analysis for Strategic Education. The recent results, fresh quarterly dividend of $0.60 per share, ongoing buybacks, and insider selling activity sit against a share price of $84.16, with a 7.10% year to date share price return and a 5...

If you are looking at Western Midstream Partners and wondering whether the current price reflects its true worth, this article will walk you through the key signals that matter. The units last closed at US$42.19, with returns of 2.5% over the past week, 4.7% over the past month, 6.2% year to date and 22.3% over the last year, plus very large gains over 3 and 5 years that may have changed how investors view its risk and reward profile. Recent news coverage has focused on Western Midstream...

If you are trying to figure out whether Stride's current share price really reflects its underlying worth, you are in the right place. Stride's share price recently closed at US$86.32, with returns of 0.5% over 7 days, 0.6% over 30 days, 33.6% year to date, a 35.2% decline over 1 year, and 100.2% and 218.8% over 3 and 5 years respectively. These figures may have investors reassessing both its growth potential and risk profile. Recent headlines around Stride have focused on its role in...

Event overview and why Pattern Group is on investors’ radar Pattern Group (PTRN) recently completed its rebrand from Covalent Group, Inc. to Pattern Group Inc., a shift that puts fresh attention on how its ecommerce acceleration model and AI driven tools might influence the stock’s appeal. See our latest analysis for Pattern Group. Pattern Group’s recent rebrand arrives after a mixed run for the shares. A 7 day share price return of 10.54% contrasts with a 90 day share price return decline of...

Why Viking Therapeutics is on investors’ radar today Viking Therapeutics (VKTX) has drawn attention after recent trading left the stock with a past 3 months total return of 186.45% and a one year total return of 9.87%. See our latest analysis for Viking Therapeutics. The recent pullback, with a 7 day share price return of a 4.43% decline and a 90 day share price return of an 18.26% decline to US$31.51, sits against a much stronger 3 year total shareholder return of 186.45%. This suggests that...

Cardinal Health (CAH) is back in focus after recent share price moves, with the stock closing at $216.02. For investors, the key question is how this current level aligns with the company’s fundamentals. See our latest analysis for Cardinal Health. The recent 1 day share price return of 3.21% decline and 7 day share price return of 4.89% decline come after a steadier period, with a 90 day share price return of 8.65% and a 1 year total shareholder return of 72.21%. This suggests longer term...

Zebra Technologies, NasdaqGS:ZBRA, has introduced its Orchestrated Care framework for healthcare. The company has also launched the DS82-HC Series scanner, focused on clinician workflows and patient safety. Both offerings are scheduled to be showcased at the HIMSS26 conference. Zebra Technologies is expanding its healthcare solutions with Orchestrated Care and the DS82-HC Series, integrating its hardware and software more closely with clinical workflows. The shares last closed at $229.67,...

PBF Energy recently highlighted its participation at several major industry conferences, including the Wolfe Research Refining Conference and the 54th Annual Scotiabank Global Energy Conference, alongside confirming an upcoming dividend for Class A shareholders following strong fourth-quarter results. These events have drawn fresh attention to PBF’s operational outlook and capital return plans at a time when pipeline idling and refinery disruptions have raised questions about the resilience...

In early March 2026, RLX Technology announced it had reported unaudited fourth-quarter and full-year 2025 results and extended its existing share repurchase program by 24 months to December 31, 2027, supported by commentary on global expansion and new product launches. The decision to prolong buybacks while emphasizing innovation, compliance, and a more diversified product portfolio offers insight into how management is aligning capital allocation with its long-term business...

White House hosts RTX and other defense executives for urgent talks on accelerating weapons and missile production tied to the ongoing Middle East conflict and munitions shortages. RTX faces supply chain risk from a U.S. mandate to remove Chinese sourced rare earths from defense systems by 2027. The company secures a major contract for the UAE Patriot Program, expanding its role in regional air and missile defense. RTX reports a technological milestone with its hybrid electric aviation...

If you are wondering whether Allient shares still offer value after a strong run, this article will walk through what the current price might be implying. The stock last closed at US$62.07, with returns of 11.7% year to date and 146.1% over the past year, even though the last 7 days and 30 days showed returns of a 7.5% decline and a 3.0% decline respectively. Recent attention on Allient has largely centered on its share price performance, with the strong 1 year return of 146.1% and 3 year...

Zillow Group, ticker NasdaqGS:ZG, has approved a new share repurchase authorization of up to $1.25b. The buyback program signals the board's confidence in the company’s approach and long term plans. The authorization adds a fresh capital return tool that could influence how investors view the stock. Zillow Group is trading at $47.01, with the stock showing a 1.1% gain over the past week, a 19.9% decline over the past month, and a 28.3% decline year to date. Over a longer horizon, the shares...

Why Ocular Therapeutix (OCUL) Is On Investors’ Radar Today Ocular Therapeutix (OCUL) has drawn attention after recent trading brought its share price to US$10.33, with returns showing a mix of gains over the past month and year and declines in the past 3 months. See our latest analysis for Ocular Therapeutix. The recent 21.39% 1 month share price return contrasts with a 17.89% 3 month share price decline, while the 1 year total shareholder return of 40.74% hints at shifting sentiment around...

In late February 2026, Sarepta Therapeutics reported fourth-quarter 2025 revenue of US$442.93 million and a net loss of US$412.23 million, alongside CEO Douglas Ingram’s plan to retire by the end of 2026 or once a successor is appointed. At the same time, the commercial launch of ELEVIDYS in Japan through Chugai and supportive analyst commentary on Sarepta’s Duchenne muscular dystrophy franchise highlighted how new gene therapy access and external confidence are influencing expectations for...

Alcoa Corporation recently announced that Emily Olson will join the company on April 6, 2026, as Executive Vice President and Chief External Affairs Officer, overseeing global government affairs, communications, stakeholder engagement, and the Alcoa Foundation as part of the Executive Team. Her deep background in sustainability, geopolitical risk and government relations across major resource companies such as Vale Base Metals, Freeport-McMoRan and BP suggests Alcoa is sharpening its focus...

JetBlue Airways (NasdaqGS:JBLU) has launched new nonstop flights to Destin, Fort Walton Beach Airport from New York and Boston. The routes expand the airline's Florida network and connect key Northeast cities with the Emerald Coast region. JetBlue Vacations has introduced a "Great Weather Guarantee" for Jamaica vacation packages, tying trip bookings directly to weather conditions. For investors watching NasdaqGS:JBLU, these moves touch two core pieces of the business: domestic leisure...

In late February 2026, Axon Enterprise, Inc. reported fourth-quarter 2025 results showing revenue rising to US$796.72 million from US$575.15 million a year earlier, while net income declined to US$2.75 million from US$135.18 million, and issued full-year 2026 guidance calling for 27% to 30% year-over-year revenue growth. The results underscored Axon’s shift toward an AI- and software-centric public safety platform, with products like its Draft One report-writing tool and recent acquisitions...

Wondering if Baker Hughes is still fairly priced after its strong run, or if the current share price is already baking in the story? This article looks at what the numbers say about value. The stock last closed at US$60.19, after a 7.3% decline over the past week, while its 30 day, year to date, 1 year and 5 year returns sit at 3.8%, 27.7%, 46.6% and 181.8% respectively. Recent coverage around Baker Hughes has focused on its role in the broader energy sector and how investors are weighing...

If you are wondering whether Kinder Morgan's current share price lines up with its underlying worth, you are not alone. That is exactly what this article will unpack. Over recent periods, Kinder Morgan's stock has closed at US$33.39, with returns of 1.0% over 7 days, 10.1% over 30 days, 20.5% year to date, 32.4% over 1 year, 128.5% over 3 years and 173.4% over 5 years. Recent news coverage has focused on Kinder Morgan as a core North American energy infrastructure company and its role in...

MPLX (MPLX) has drawn attention after recent trading left the unit price near $58.66, with the partnership noting multi year total returns and operating a broad midstream footprint across U.S. pipelines, storage, and logistics. See our latest analysis for MPLX. At a share price of US$58.66, MPLX has seen a 6.13% 1 month share price return and 8.89% year to date share price return, while its 1 year total shareholder return of 21.30% and 5 year total shareholder return of 249.01% point to...